Health Catalyst, Inc. (HCAT) stock
HCATNasdaqServices-Computer Programming, Data Processing, Etc.Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/3075% below fair value
$1.51+0.15 (+11.03%)
Close on Nov 13, 2026Market cap $113.64MP/E –Yield –
Health Catalyst statistics
88 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Mar 11, 2027 (estimated, after the close)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 1.35
- 4.73
- P/OCF Ratio
- 4.24
- 12.99
Enterprise valuationIndustry
- EV / Sales
- 0.13
- 2.10
- EV / FCF
- 1.35
- 15.48
Share statisticsIndustry
- Shares Change (YoY)
- 8.32%
- 1.88%
- Shares Change (QoQ)
- 2.09%
- 0.04%
- Float
- 47M
- 53M
- Shares Held by Insiders
- 37.8%
- 13.1%
- Shares Held by Institutions
- 69.4%
- 62.6%
Short sellingIndustry
- Short Interest
- 2M
- –
- Short Interest Change
- -5.56%
- -3.30%
- Short % of Float
- 4.17%
- 5.82%
- Short % of Shares Outstanding
- 2.59%
- 4.22%
- Days to Cover
- 7.18
- 3.54
Stock price statisticsIndustry
- 52-Week High
- $3.02
- –
- 52-Week Low
- $0.96
- –
- 20-Day Moving Average
- $1.60
- –
- 50-Day Moving Average
- $1.69
- –
- 200-Day Moving Average
- $1.68
- –
- Average True Range (14)
- $0.13
- –
- Price Change (1 Week)
- 3.42%
- 0.50%
- Price Change (1 Month)
- -16.1%
- -1.81%
- Price Change (3 Months)
- -11.2%
- -4.67%
- Price Change (6 Months)
- 26.9%
- 0.47%
- Price Change (YTD)
- -36.8%
- -13.6%
- Price Change (1 Year)
- -38.6%
- -13.9%
- Price Change (3 Years)
- -81.9%
- -16.1%
- Price Change (5 Years)
- -96.9%
- -57.0%
- Average Volume (10 Days)
- 440,485
- –
- Average Volume (20 Days)
- 362,514
- –
- Average Volume (90 Days)
- 563,367
- –
- Relative Volume
- 0.82
- 0.64
- Relative Strength Index (14)
- 45.1
- 47.4
- Volatility (1 Year)
- 92.1%
- 65.4%
- Beta (5 Years)
- 1.83
- 1.19
MarginsIndustry
- EBITDA Margin
- -48.9%
- 0.72%
- FCF Margin
- 9.45%
- 9.88%
Returns on capitalIndustry
- Return on Equity (ROE)
- -84.6%
- 1.34%
- Return on Assets (ROA)
- -49.0%
- -3.24%
- Return on Invested Capital (ROIC)
- -61.4%
- -0.09%
- Return on Capital Employed (ROCE)
- -112.3%
- -0.55%
Financial positionIndustry
- Current Ratio
- 1.70
- 1.37
- Quick Ratio
- 1.54
- 0.94
- Debt / Equity
- 0.00
- 0.51
- Debt / FCF
- 0.00
- 2.79
GrowthIndustry
- Revenue Growth (YoY)
- -13.9%
- 9.45%
- Revenue Growth (3Y CAGR)
- 4.05%
- 7.44%
- Revenue Growth (5Y CAGR)
- 10.5%
- 12.3%
EfficiencyIndustry
- Asset Turnover
- 0.66
- 0.64
- Revenue Per Employee
- $226.84K
- $394.08K
- Profits Per Employee
- -$168.41K
- -$7.02K
- Employee Count
- 1,200
- 525
- WACC
- 14.2%
- 10.3%
Income statement (TTM)Industry
Balance sheetIndustry
- Net Cash (Debt)
- $78.99M
- $1.76M
- Net Cash Per Share
- $1.05
- $0.12
- Equity (Book Value)
- $145.59M
- $51.00M
- Book Value Per Share
- $1.93
- $1.98
- Tangible Book Value
- $84.41M
- $2.87M
- Working Capital
- $54.82M
- $16.25M
Cash flow (TTM)Industry
- Capital Expenditures
- -$1.11M
- -$5.67M
- FCF Per Share
- $0.34
- $0.53
Dividends and yieldsIndustry
- Earnings Yield
- -177.8%
- 0.37%
- FCF Yield
- 22.6%
- 4.39%
- Buyback Yield
- 0.00%
- 3.39%
- Shareholder Yield
- 0.00%
- 3.74%
Taxes and interestIndustry
- Income Tax
- $715.00K
- $1.63M
Scores and fair valueIndustry
- Altman Z-Score
- -9.02
- 1.96
- Piotroski F-Score
- 4
- 5
- Beneish M-Score
- -3.92
- -2.82
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | HCAT | S&P 500 | Difference | HCAT per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -13.2% | -3.0% | −10.2 pts | ||
| 3 months | -13.7% | -2.8% | −10.9 pts | ||
| Year to date | -36.8% | +11.5% | −48.3 pts | ||
| 1 year | -35.7% | +13.5% | −49.2 pts | ||
| 3 years | -79.5% | +77.7% | −157.2 pts | -41.1% | +21.1% |
| 5 years | -96.9% | +72.6% | −169.5 pts | -50.1% | +11.5% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
2M HCAT shares were sold short on Oct 30, 2026, down 5.6% from the previous report, or 4.17% of the shares available to trade. At recent volumes it would take 7.2 days to buy them back. Over the last 20 sessions, 37.9% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 1,952,692 | -5.6% | 271,857 | 7.2 |
| Oct 15, 2026 | 2,067,651 | -6.6% | 473,737 | 4.4 |
| Sep 30, 2026 | 2,212,809 | +9.1% | 425,909 | 5.2 |
| Sep 15, 2026 | 2,028,738 | +4.0% | 516,664 | 3.9 |
| Aug 31, 2026 | 1,951,385 | -14.8% | 477,347 | 4.1 |
| Aug 14, 2026 | 2,290,367 | -23.3% | 1,395,651 | 1.6 |
| Jul 31, 2026 | 2,986,245 | -18.1% | 493,067 | 6.1 |
| Jul 15, 2026 | 3,645,405 | -20.7% | 965,372 | 3.8 |
| Jun 30, 2026 | 4,597,012 | -27.6% | 2,166,281 | 2.1 |
| Jun 15, 2026 | 6,349,157 | -3.6% | 4,071,420 | 1.6 |
| May 29, 2026 | 6,585,307 | -8.6% | 531,628 | 12.4 |
| May 15, 2026 | 7,208,853 | -5.0% | 643,628 | 11.2 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?